Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Ampio Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 36 | 35 | −1 |
| Shares | 543.7K | 425.8K | −117.9K (−21.7%) |
| Value | $124.7K | $98.8K | −$25.9K (−20.8%) |
New holders (3)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IHT Wealth Management, LLC | 23,937 | $5.58K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 10,723 | $2.50K | 0.00% |
| Sanctuary Wealth Management, L.L.C. | 268 | $62 | 0.00% |
Sold out (4)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 40,162 | $9.00K |
| Goldman Sachs Group Inc | 12,921 | $3.01K |
| Citadel Advisors LLC | 7,642 | $1.78K |
| WealthPLAN Partners, LLC | 167 | $39 |